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Human E4B, also called UFD2a, is a Ubox-containing
protein that functions as an E3 ubiquitin ligase and an
E4 polyubiquitin chain elongation factor. E4B is
thought to participate in the proteasomal degrada-
tion of misfolded or damaged proteins through asso-
ciation with chaperones. The U box domain is an
anchor site for E2 ubiquitin-conjugating enzymes,
but little is known of the binding mechanism. Using
X-ray crystallography and NMR spectroscopy, we
determined the structures of E4B U box free and
bound to UbcH5c and Ubc4 E2s. Whereas previously
characterized U box domains are homodimeric, we
show that E4B U box is a monomer stabilized by
a network of hydrogen bonds identified from scalar
coupling measurements. These structural studies,
complemented by calorimetry- and NMR-based
binding assays, suggest an allosteric regulation of
UbcH5candUbc4byE4BUbox andprovide amolec-
ular basis to understand how the ubiquitylation
machinery involving E4B assembles.
INTRODUCTION
The covalent modification of proteins with ubiquitin or polyubi-
quitin chains regulates many cellular processes including protein
degradation, cellular trafficking, DNA repair, and DNA lesion
bypass (Weissman, 2001; Passmore and Barford, 2004; Pickart
and Eddins, 2004). Ubiquitylation involves a cascade of enzy-
matic reactions (Pickart, 2001) where ubiquitin is transferred
from an E1 ubiquitin-activating enzyme to an E2 ubiquitin-conju-
gating enzyme, forming a thioester conjugate with a cysteine of
E2. E2 associates with an E3 ubiquitin ligase, which recognizes
a protein substrate and facilitates the transfer of ubiquitin from
E2 to the z-amino group of a lysine residue in the substrate
(Ye and Rape, 2009). In some instances, a chain elongationStructure 18, 95factor E4 catalyzes polyubiquitin chain assembly in place of or
after E3 ubiquitylation (Kuhlbrodt et al., 2005).
There are three classes of E3 ubiquitin ligases, defined by the
presence of a HECT, RING, or U box domain. The RING and
U box domain have the same fold but, unlike the RING domain,
the U box does not coordinate Zn2+ ions (Aravind and Koonin,
2000; Ohi et al., 2003). HECT E3s form a catalytic ubiquitin thio-
ester intermediate before transferring ubiquitin to an acceptor
protein (Huang et al., 1999), whereas RING and U box E3s func-
tion as adaptors that bring in close proximity the ubiquitin-linked
E2 and a target protein, with the RING or U box domain being the
anchor site for E2s. Binding of the RING domain was shown to
activate the release of ubiquitin from E2 and this likely applies
to the U box domain as well, but the activation mechanism is
not known (Ozkan et al., 2005; Deshaies and Joazeiro, 2009).
Overall, our understanding of the ubiquitin transfer mechanism
fromE2-E3/E4 to substrate is rudimentary, and this is particularly
true for U box proteins.
Saccharomyces cerevisiae Ufd2 (ubiquitin fusion degradation
protein 2), the first chain elongation factor E4 to be described,
has been shown to promote polyubiquitylation of artificial fusion
proteins and is the prototype U box protein (Koegl et al., 1999).
Ufd2 binds the chaperone cdc48 component of the Ufd1-Npl4-
cdc48 complex that facilitates the translocation of polyubiquity-
lated proteins from the endoplasmic reticulum into the cytosol
for subsequent degradation by the 26S proteasome (Richly
et al., 2005). Several other members of the U box family of ubiq-
uitin ligases interact with chaperones or chaperone binding
proteins, suggesting a general function of U box-containing
ubiquitin ligases in the proteosomal degradation of misfolded
or damaged proteins (Hatakeyama et al., 2004). The mammalian
homolog of Ufd2, called UFD2a or E4B, is also a U box-contain-
ing E4 enzyme that was shown to promote the degradation of
a pathological form of ataxin-3, the gene product implicated in
Machado-Joseph disease (Matsumoto et al., 2004). Human
E4B functions as an E3 ubiquitin ligase as well in vitro when
provided with the human E2-conjugating enzymes Ubc4 or
UbcH5c (Hatakeyama et al., 2001).
The mechanism by which U box ubiquitin ligases function
together with E2-conjugating enzymes is poorly understood.5–965, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 955
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Figure 1. Solution and Crystal Structures of E4B U Box
(A) Superposition of the 20 lowest-energy NMR structures of E4B U box in stereoview showing the N, Ca, and C0 trace for aa 1228–1300. The a helices (H),
b strands (B), and loops (L) are indicated.
(B) Ribbon representation of the NMR structure of E4B U box showing residues 1226–1302 and amino acid side chains (yellow) forming two hydrophobic cores.
(C) Overlay of the crystal (aa 1226–1300) and NMR (aa 1226–1300) structures of E4BU box, where a helices (H), b strands (B), and loops (L) are indicated. See also
Figure S1.
Structure representations were prepared using MOLMOL (Koradi et al., 1996) or PyMOL (http://pymol.sourceforge.net).
Structure
Interaction of E4B U Box with UbcH5c and Ubc4A molecular understanding of these enzymes is limited, with
only one U box protein—CHIP (C-terminal Hsp70-interacting
protein)—that has been characterized structurally in complex
with different E2s (Xu et al., 2008; Zhang et al., 2005). Here we
show that unlike CHIP and all other isolated U box domains char-
acterized to date, human E4B U box is a monomer, both in the
free state and in complex with human UbcH5c or Ubc4 E2
enzymes. We present the nuclear magnetic resonance (NMR)
solution structure of E4B U box, including an NMR-based char-
acterization of a hydrogen-bond network in the U box domain.
We also present the crystal structures of human E4B U box,
Ubc4, and E4B U box in complex with UbcH5c. Data from
NMR chemical shift mapping validate the crystal structure of
E4B U box–UbcH5c in solution and suggest a possible allosteric
regulation of UbcH5c and Ubc4 by E4B U box.
Our structural studies of the interactions of human E4B with
UbcH5c and Ubc4, combined with previously published struc-
tures of budding yeast Ufd2 (Tu et al., 2007) and human UbcH5c
bound to ubiquitin (Brzovic et al., 2006), provide a molecular
framework to better understand the mechanism by which U
box-containing ubiquitin ligases function.
RESULTS
Solution Structure of the U Box Domain of E4B
As a prelude to structure determination, we evaluated the oligo-
merization state of a region of human E4B, amino acids (aa)
1208–1302, that encompasses the U box domain. The strong
signals observed for this protein construct and the absence of
changes in chemical shifts in the 1H-15N heteronuclear single
quantum coherence (HSQC) NMR spectrum of E4B as a function956 Structure 18, 955–965, August 11, 2010 ª2010 Elsevier Ltd All riof protein concentration in the 0.4–2.0 mM range suggested
that E4B U box was a monomer. This is unlike other U box
domains characterized to date, which dimerize in this concentra-
tion range (Andersen et al., 2004; Vander Kooi et al., 2006).
Consistent with a monomeric state, as explained below in the
analysis of isothermal titration calorimetry (ITC) data, a control
ITC dilution experiment that we performed with an initial high
concentration (i.e., 3 mM) of E4B U box did not reveal any
marked change in heat signal that could be attributed to oligomer
dissociation in the calorimeter cell. Dynamic light-scattering
measurements also suggested an apparent molecular weight
of 11 kDa, which coincides with the molecular weight of a mono-
meric E4B U box domain (data not shown). We note with interest
that the full-length Ufd2 protein, thought to be the homolog of
E4B in budding yeast, is also a monomer in solution (Tu et al.,
2007).
The structure of E4B U box (aa 1208–1302) was determined
using NMR spectroscopy (Figures 1A and 1B). The average pair-
wise root-mean-square deviation (rmsd) among the 20 best-
calculated structures superimposed on the backbone and all
heavy atoms from residues 1228–1295 are 0.62 and 1.17 A˚,
respectively. The structural statistics are summarized in Table 1.
The first 20 N-terminal amino acids of the E4B construct used for
structure determination (aa 1208–1302) lack a defined confor-
mation and connect to a long loop (L1: Ala1228–Asp1243) that
extends to a first b strand (B1: Pro1244–Leu1247). B1 forms
a b hairpin with b strand 2 (B2: Thr1251–Asp1254), and together
with b strand 3 (B3: Glu1281–Pro1282) constitute a central three-
stranded antiparallel b sheet. Following B2 is a central a helix
(H1: Arg1255–His1261) that connects to a second loop (L2:
Leu1262–Leu1280), and then to b strand B3. B3 leads toghts reserved
Table 1. NMR and Structure Refinement Statistics for E4B (aa
1208–1302)
Number of restraints
Total NOE restraints 1368
Intraresidue 64
Sequential (ji  jj = 1) 384
Medium-range (1 < ji  jj < 4) 409
Long-range (ji  jj > 4) 511
Hydrogen-bond restraints 36
Dihedral-angle restraints
F 23
J 23
Structure statisticsa
Violations (mean ± standard deviation)
NOE restraints (A˚) 0.005 ± 0.001
Dihedral-angle restraints () 0.059 ± 0.045
Rmsds from idealized geometry
Bond lengths (A˚) 0.0011
Bond angles () 0.396
Improper torsions () 0.251
Final energies (kcal$mol1)
Total 85.0 ± 2.7
Bonds 1.9 ± 0.2
Angles 70.3 ± 1.5
van der Waals 3.2 ± 0.7
NOEs 1.7 ± 0.6
Coordinate precision (A˚)b
Rmsds
Backbone atoms (aa 1228–1295) 0.62
Backbone in secondary structures 0.48
Heavy atoms (aa 1228–1295) 1.17
Heavy atoms in secondary structures 1.07
Ramachandran plot
Preferred regions (%) 59.1 ± 5.9
Allowed regions (%) 40.0 ± 5.5
Outliers (%) 0.9 ± 1.2
aStructure statistics refer to an ensemble of 20 structures with lowest
energies from 100 calculated structures.
b Average pairwise rmsd for the ensemble of 20 structures.
Table 2. Crystallography Statistics
E4B U Box Ubc4
E4B U
Box–UbcH5c
Data Collection
Space group P432 P1211 P622
Cell dimensions
a, b, c (A˚) 83.40, 83.40,
83.40
28.23, 59.12,
45.42
142.71, 142.71,
83.13
a, b, g () 90, 90, 90 90, 106.73, 90 90, 90, 120
Resolution (A˚) 24.07–2.60
(2.64–2.60)
43.31–1.60
(1.64–1.60)
32.79–3.17
(3.23–3.17)
Rsym or Rmerge 0.139 (0.655) 0.061 (0.123) 0.192 (0.777)
I/sI 46.2 (7.3) 17.1 (13.2) 18.1 (6.2)
Completeness (%) 98.6 (99) 99.9 (99.5) 92.2 (96.0)
Redundancy 37.0 (36.7) 3.7 (3.6) 58.8 (57.6)
Refinement
Resolution (A˚) 24.07–2.60 43.41–1.60 32.79–3.17
Number of reflections 3,328 17,905 8,196
Rwork/Rfree 0.185/0.254 0.189/0.229 0.236/0.279
Number of atoms 657 1449 1865
Protein 624 1246 1850
Ligand/ion N/A N/A N/A
Water 33 203 15
B factors
Protein 42.58 5.158 93.63
Ligand/ion N/A N/A N/A
Water 41.52 18.27 65.53
Rmsds
Bond lengths (A˚) 0.002 0.023 0.003
Bond angles () 0.588 2.018 0.689
Ramachandran plot
Preferred regions (%) 94.3 94.9 88.5
Allowed regions (%) 5.7 4.4 6.6
Outliers (%) 0 0.7 4.9
Data for the highest resolution shell are shown in parentheses. N/A, not
applicable.
Structure
Interaction of E4B U Box with UbcH5c and Ubc4a second a helix (H2: Pro1284–Arg1295) and finally to a 7
residue unstructured C-terminal segment (Glu1296–His1302).
Two hydrophobic cores are present in E4B U box. The first
hydrophobic core holds together the central a helix H1 and the
region surrounding the central b sheet, whereas the second
core involves the C-terminal a helix H2 packing against loop L1
(Figure 1B). The overall fold of E4B is similar to that of other U
box domains (Andersen et al., 2004; Ohi et al., 2003; Xu et al.,
2006; Zhang et al., 2005).
Crystal Structure of the E4B U Box Domain
To complement the NMR spectroscopy study, we determined
the crystal structure of the U box domain of E4B (aa 1208–
1302) at a resolution of 2.6 A˚ (Figure 1C). The crystallographyStructure 18, 95statistics are provided in Table 2. Crystals grew in space group
P432, with one molecule of E4B per asymmetric unit, consistent
with a monomeric structure. Phasing was done by molecular
replacement (MR) using the NMR-derived structure of E4B. Final
R factors are Rwork = 18.5% and Rfree = 25.4%. The electron
density is clear for most of the U box domain, the only disordered
parts being the N-terminal residues 1208–1225 and C-terminal
residues 1301–1302. These are the same regions of the NMR
structure that lacked a defined conformation. The 2Fo – Fc
sA-weighted electron density map for E4B is shown in Fig-
ure S1A,available online.
The crystal structure and averageNMR structure superimpose
well, with an rmsd of 1.04 A˚ for the backbone atoms N, Ca,
and C0 of residues 1228–1299 (Figure 1C). In the crystal lattice,
there is no pairing of U box domains corresponding to the
previously identified interface in homodimeric U box proteins,
a result also consistent with the monomeric nature of E4B U
box (Figure S1B).5–965, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 957
Figure 2. Identification of Hydrogen Bonds in E4B U Box by NMR Spectroscopy
(A) A region from the constant time 3D J-HNCO NMR spectrum of E4B U box showing peaks correlated through 1JNC0,
2JNC0,
3JNCg, and
h3JNC0 scalar couplings.
(B) The 19 H bonds in E4B U box that are listed in Table S1 were identified through h3JNC0 scalar coupling measurements. The dotted lines represent these
H bonds. Residues Asp1232 and Asp1268 for which side-chain 3JNCg scalar couplings were measured are shown. Asp1232 and Asp1268 correspond to the
zinc binding regions of RING domains.
(C) Asp1232 and Asp1268 of E4B U box approximately occupy the zinc centers (purple spheres) in c-Cbl RING domain (PDB ID code 1FBV) when the U box and
RING domains are superimposed. H bonds involving the two aspartate side chains were determined from 3JNCg scalar coupling measurements and are shown by
the dashed lines.
(D) Calibration curve for the dihedral-angle (c1) dependence of
3JNCg scalar couplings in aspartate and asparagine residues. Blue and red points correlate exper-
imental 3JNCg and corresponding c1 angle values from the crystal structure of E4B U box. The red points correspond to residues for which a side-chain carbonyl
participates in an H bond as determined from 3JNCg scalar couplings. See also Table S1 for the values of measured coupling constants.
Structure
Interaction of E4B U Box with UbcH5c and Ubc4Hydrogen-Bond Network in E4B Determined
Experimentally from Scalar Couplings
An extensive hydrogen-bond (H bond) network is predicted from
the solution and crystal structures of E4B U box. Canonical
H–N$$$O=C H bonds can be detected experimentally via long-
range h3JNC0 scalar couplings that connect the
15N nucleus of
the donor amino acid to the carbonyl 13C nucleus of the acceptor
(Cordier and Grzesiek, 1999). From such measurements in E4B,
a total of 19 H bonds were unambiguously identified. Twelve are
backbone H bonds that link interstrand residues in the b sheet as
well as i and i + 4 residues within the central and C-terminal
helices (Figures 2A and 2B; Table S1). Seven H bonds were iden-
tified in loop regions (Table S1).
From comparison of the structures of E4B U box and the
C3HC4-type zinc binding RING finger motif of c-Cbl (Zheng
et al., 2000), E4B residues Asp1234, Met1237, Asp1254, and
Ser1256 are found to approximate the histidine and cysteine
residues in the first zinc binding site of the RING motif. Similarly,
Ser1249, Thr1251, Asp1268, and Asn1271 are the residues
corresponding to the second zinc binding site (Figure 2C).
Noticeably, the carboxylate groups of Asp1234 and Asp1268
roughly occupy the place of cationic zinc metal centers in the
first and second zinc binding sites in the RING motif, respec-
tively. Supporting this observation, the side-chain carbonyls
of Asp1234, Asp1254, and Asp1268 were identified through
3JNCg scalar couplings to be involved in H bonds (Figures 2B
and 2C; Table S1). The dihedral angles c1 (defined by atoms
N-Ca-Cb-Cg) measured for Asp1234, Asp1254, and Asp1268 in
the crystal structure of E4B U box and the corresponding958 Structure 18, 955–965, August 11, 2010 ª2010 Elsevier Ltd All riexperimental 3JNCg scalar couplings are in good agreement
with the predicted dependence of 3JNCg on c1 values (Juranic
et al., 2005) (Figure 2D). This is consistent with the aspartate
side chains adopting a defined conformation in solution. Notice
that 3JNCg scalar couplings for E4B surface Asp1238 and
Asp1243 are not predictive of the angles measured in the crystal
structure (angle differenceR 30), an indication that these side
chains are in a state of free rotation around c1 in solution.
3JNCg values for other aspartate and asparagine residues of
E4B are consistent with the c1 dihedral angles measured in the
crystal structure (Figure 2D). Taken together, our data show
that the U box motif is stabilized by a network of H bonds with
some H bonds substituting for Zn+2 chelation in RING domains.
Comparison of E4B U Box Monomer to Dimeric U Box
Domains
E4B U box is monomeric unlike all other U box domains charac-
terized previously, which have a conserved dimeric topology
(Vander Kooi et al., 2006; Xu et al., 2006; Zhang et al., 2005).
This difference in oligomerization state can be understood
from comparison of the structure and amino acid sequence
of E4B U box to those of dimeric U box proteins such as CHIP
or Prp19 (Figures 3A and 3B). In mouse CHIP, homodimerization
is mediated by the hydrophobic residues Tyr231, Ile246, Ile282,
and Ala286 and an asparagine (Asn284) that forms H bonds with
the same residue of the complementary CHIP molecule. The
corresponding first four residues in human E4B are all charged:
Glu1231, Arg1246, Glu1281, and Glu1285, and two are con-
served in S. cerevisiae Ufd2 (Figure 3A). The hydrophobic natureghts reserved
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Figure 3. Electrostatic Surface Potentials of E4B and CHIP U Box Domains Affect Oligomerization States
(A) Sequence alignment of U box domains from different E3 ubiquitin ligases indicating locations of secondary-structure elements. CHIP and Prp19 are dimers
whereas Ufd2 and E4B are monomers. Key CHIP and Prp19 residues mediating homodimerization are highlighted. Hydrophobic residues in CHIP and Prp19
(green box) correspond to charged residues in E4B, whereas an asparagine residue (Asn284) in mouse CHIP (blue box) is replaced by a valine residue
(Val1283) in human E4B.
(B) Molecular representation of mouse CHIP homodimer showing the important dimerization interface residues described in (A).
(C) Electrostatic surface potential of mouse CHIP U box homodimer (PDB ID code 2C2V) showing predominantly nonpolar character at the dimerization interface.
The foremost protomer is rendered transparent for clarity.
(D) Electrostatic surface potential of a hypothetical homodimer of E4B U box showing a negatively charged dimer interface.
Structure
Interaction of E4B U Box with UbcH5c and Ubc4of the interface in CHIP is in stark contrast with the correspond-
ing negatively charged surface of a hypothetical E4B dimer, likely
explaining the monomeric state of human E4B U box (Figures 3C
and 3D). This also applies to mouse E4B U box, whose NMR
structure was reported recently (Nordquist et al., 2010). Despite
the dissimilarities in oligomerization states of E4B and CHIP U
boxes, we note that full-length mouse CHIP has an asymmetric
conformation in which the E2 binding site of one of the U box
domains is blocked (Zhang et al., 2005). Thus, a CHIP dimer,
like the E4B monomer, only binds one E2 ubiquitin-conjugating
enzyme.
Structure of the Complex of Human E4B U Box
and UbcH5c
The ability of the human ubiquitin ligase E4B to participate in
its own ubiquitylation and that of bacterial substrates was
shown previously (Hatakeyama et al., 2001). In these in vitro
assays, E4B was mixed with E1, different E2 enzymes, ubiquitin,
and bacterial lysate, and then immunoblotted with antibodies
against ubiquitin to detect the ubiquitylation that occurred
(Hatakeyama et al., 2001). These experiments showed that ubiq-
uitylation required the U box domain of E4B and that the
enzymatic reaction was most efficient with the E2-conjugating
enzymes UbcH5c and Ubc4. Little enzymatic activity was
detected when other E2s including Ubc2a, Ubc2b, Ubc3,
UbcH6, UbcH7, and UbcH8 were present.
Using ITC, we confirmed the interaction of E4B U box and full-
length UbcH5c (aa 1–147) and Ubc4 (aa 1–147). A dissociation
constant (KD) of 67.1 ± 5.4 mM at 22
C was determined for the
E4B U box–UbcH5c interaction with a stoichiometry close to
unity (n = 0.99 ± 0.05) (Figure 4A). The interaction is endothermicStructure 18, 95with an unfavorable observed enthalpy change (DHobs =
2.9 kcal$mol1) but is entropically favored (TDSobs =
8.5 kcal$mol1). Similar thermodynamic parameters were
obtained for the calorimetric titration of Ubc4 with E4B U box
(data not shown). The control ITC dilution experiment in which
E4B U box is injected into a buffer solution does not show any
marked change in heat of dilution as the concentration of E4B
U box increases in the calorimeter cell, consistent with a mono-
meric state of E4B U box (Figure 4A).
To gain additional insight into these interactions, we attemp-
ted crystallization of E4B U box in complex with Ubc4 and
UbcH5c. From these trials, we initially obtained crystals of
Ubc4 (aa 1–147) alone and determined its structure to a resolu-
tion of 1.6 A˚ by MR using the atomic coordinates of UbcH5c
(Protein Data Bank [PDB] ID code 1X23) (Figure S2A). The final
R factors are Rwork = 18.9% and Rfree = 22.9%. Refinement
statistics are summarized in Table 2. The crystals have a space
group of P21 and contain one molecule of Ubc4 in the asym-
metric unit. The electron density is well defined, as illustrated
by the 2Fo – Fc sA-weighted map shown in Figure S2B.
We were able to determine the crystal structure of UbcH5c
(aa 1–147) in complex with the U box domain of human E4B
(aa 1208–1302) to a resolution of 3.17 A˚ (Figure 4B). The crystals
have one molecule each of UbcH5c and E4B U box per asym-
metric unit in the space group P622. Phasing was done by
MR using the crystal structures of free human Ubc4 and E4B
U box, both from this study, as starting models. The final
R factors are Rwork = 23.6% and Rfree = 27.9%, and refinement
statistics can be found in Table 2. The resulting electron density
map has a good fit for most regions of E4B and UbcH5c, except
for the first 18 N-terminal residues (aa 1208–1225) and last two5–965, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 959
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Figure 4. Interaction of E4B U Box with UbcH5c and Ubc4 E2-Conjugating Enzymes
(A) Isothermal titration calorimetry of UbcH5c with E4B U box. Shown are the integrated heat measurements from injecting 3 mM E4B U box into the calorimeter
cell containing UbcH5c at an initial concentration of 100 mM (top panel) or buffer solution (middle panel). A standard one-site model was used for curve fitting
(bottom panel) in the determination of KD and stoichiometry (n), the values of which are shown.
(B) Crystal structure of human E4B U box in complex with UbcH5c.
(C) Crystal structure of mouse CHIP U box in complex with Ubc13 (PDB ID code 2C2V).
(D) Crystal structure of the human c-Cbl RING E3 ligase in complex with UbcH7 (PDB ID code 1FBV). See also Figure S2.
Structure
Interaction of E4B U Box with UbcH5c and Ubc4C-terminal residues (1301 and 1302) of E4B, which are not visible
in the electron density. These regions of the protein also lack
a stable conformation in the solution and crystal structures of
E4B (vide supra). Ten surface residues of UbcH5c and nine of
E4B with long side chains—arginine, lysine, or methionine—are
poorly defined with incomplete electron density. In the protein
cores and at the interface of the two proteins in the crystal, all
residues have electron density guiding their position. A 2Fo –
Fc sA-weighted electron density map is shown in Figure S3.
Noticeably, of the three crystals used to elucidate the E4B U
box–UbcH5c structure, all had amissing layer of electron density
equal to one-third of the unit cell. This is likely due either to one-
dimensional twinning or another crystalline disorder(s). The lack
of electron density could originate from the N- and C-terminal
flexible segments of E4B, which point toward the disordered
region of the crystals. No crystals of the complex could be
obtained with shorter versions of E4B. Further remarks on this
subject are presented in Supplemental Discussion.
In the crystal, the most energetically favorable interface
between E4B U box and UbcH5c, as determined using PISA
(Krissinel and Herrick, 2007), occurs along each of the crystallo-
graphic six-fold symmetry axes. As explained below, this also
corresponds to the binding site identified in solution using
NMR spectroscopy. The relative positioning of the two proteins
is such that H1, L4, and L7 of UbcH5c make contacts with L1,
H1, and L2 of E4B, respectively (Figure 4B). Polar interactions
at the interface include a salt bridge between E4B U box
Asp1238 and UbcH5c Lys8 (Figure 5A). Based on (N)H$$$O(C)
distances shorter than 3.8 A˚, there likely are intermolecular
H bonds involving the following atoms: E4B-Leu1236 O and
UbcH5c-Arg5 NH1, E4B-Pro1269 O and UbcH5c-Ser94 OG,
E4B-Asn1264 ND2 and UbcH5c-Phe62 O, E4B-Asn1264 O960 Structure 18, 955–965, August 11, 2010 ª2010 Elsevier Ltd All riand UbcH5c-Lys63 NZ, and E4B-Arg1272 and Gln92 OG1
(Figure 5A). There are three hydrophobic clusters at the interface.
The first, composed of Leu1236, Met1237, Ile1257, Arg1260,
His1261, and Asn1264 of E4B, forms a deep pocket where
Phe62 of UbcH5c is completely buried (Figure 5B). With
Arg1260 close to Phe62 at 4.5 A˚, there is a possible cation–p
interaction between the guanidinium group and the phenyl
ring. A similar cation–p interaction is present in mouse and
zebrafish CHIP U box complexes (Xu et al., 2008; Zhang et al.,
2005). The second cluster, composed of Leu1236, Met1253,
His1261, Pro1269, and Phe1270 of E4B, forms a channel
in which Ser94, Pro95, and Ala96 of UbcH5c are located (Fig-
ure 5B). This UbcH5c motif, termed S-P-A, is conserved and is
part of a similar interface in the E2-E3 structures of mouse and
zebrafish CHIP in complex with Ubc13 and UbcH5a, respec-
tively (Xu et al., 2008; Zhang et al., 2005), and in the RING domain
protein TRAF2 bound to Ubc13 (Yin et al., 2009). The final hydro-
phobic cluster encompasses E4B Leu1236 and Met1237, which
both contact the surface of UbcH5c made up of Ala2, Leu3,
Lys4, Arg5, and Lys8 (Figure 5C). Overall, the E4B–UbcH5c inter-
face resembles those of other E2-E3 complexes such as CHIP-
Ubc13-Uev1a (Zhang et al., 2005) and c-Cbl-UbcH7 (Zheng
et al., 2000) where the E3 is a U box- or RING domain-containing
protein (Figures 4C and 4D).
Mapping the E4B Interaction Interface with UbcH5c
and Ubc4 in Solution
To further probe howE4BUbox bindsUbcH5c andUbc4 in solu-
tion and validate the crystal structure of E4B U box–UbcH5c
complex, we acquired a series of 1H-15N HSQC NMR spectra
on 15N-labeled E4B U box, alone and titrated with nonlabeled
Ubc4 (aa 1–147) or UbcH5c (aa 1–147) (Figures 6A and 6B).ghts reserved
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Figure 5. Interaction Interface between E4B U Box and UbcH5c
(A) E4B U box and UbcH5c interface showing possible salt bridges and hydrogen bonds.
(B) E4B U box and UbcH5c interface showing how F62 and S94-P95-A96 (S-P-A motif) of UbcH5c interact with E4B U box.
(C) E4BU box andUbcH5c interface illustrating how L1236 andM1237 of E4BU box interact with UbcH5c. See also Figure S3 for the electron density map of E4B
U box–UbcH5c complex.
Structure
Interaction of E4B U Box with UbcH5c and Ubc4Only one set of E4B signals was observed during the entire titra-
tion with either UbcH5c or Ubc4. A subset of these signals
shifted and broadened, indicating that the exchange between
E4B in the free state and bound to Ubc4 or UbcH5c is fast
to intermediate on the NMR chemical shift timescale. This
exchange regime is consistent with the KD of 67.1 ± 5.4 mM for
the E4B U box–UbcH5c interaction derived from ITC measure-
ments (Figure 4A). The E4B residues for which changes occurred
in the 1H-15N HSQC spectrum during titration by Ubc4 or
UbcH5c were mapped on the structure of E4B. As shown in
Figure 6C, these residues are all in the vicinity of the most
favorable binding interface identified in the crystal structure of
E4B U box–UbcH5c complex.
To identify the binding site of the E2-conjugating enzymes,
complementary NMR experiments were performed where 15N-
labeled Ubc4 and UbcH5c were titrated with nonlabeled E4B
U box (Figures 6D and 6E). For these studies, we used the previ-
ously published resonance assignments of human Ubc4 (Farrow
et al., 2000). Because of the 97% amino acid sequence identity
between Ubc4 and UbcH5c and their similar structures, these
assignments could also be used for UbcH5c (Jensen et al.,
1995). As expected, the chemical shift changes observed for
the two E2 enzymes were similar (Figures 6D and 6E). Residues
exhibiting chemical shift perturbations were highlighted in the
crystal structure of E4B U box–UbcH5c. Perturbed resonances
primarily come from residues in loops L4 and L7 and the
N-terminal helix H1 of UbcH5c, and fit well the binding interface
seen in the crystal structure of E4B U box–UbcH5c complex
(Figure 6F). This demonstrates a close agreement between the
binding interface in solution and in the crystalline state.
Interestingly, six residues conserved in Ubc4 and UbcH5c that
are distant from the binding interface also experience shifts in
their NMR signals upon interaction with E4B U box (Figure 6G).
As discussed next in light of previous work on the interactionStructure 18, 95of UbcH5b and the RING domain of E3 ubiquitin ligase CNOT4
(Dominguez et al., 2004; Ozkan et al., 2005), the observed
changes in chemical shifts suggest that E4B U box could regu-
late UbcH5c and Ubc4 through an allosteric mechanism.
DISCUSSION
The question of whether U box and related RING E3 ubiquitin
ligases are only adaptor proteins that bring substrate and E2 in
close proximity or contribute also to an induced activating
conformational change in their cognate E2 enzymes has been
subject to debate (Deshaies and Joazeiro, 2009). The crystal
structure of human E4BU box–UbcH5c complex does not reveal
any change in conformation when compared to the structures of
the two proteins in their unbound state. NMR spectroscopy is
a very sensitive technique to probe changes in conformations.
As mentioned above, upon complex formation, shifts in 1H and
15N signals of surface residues of E4B U box and UbcH5c map
to the binding interface identified in the crystal structure,
therefore validating this interface in solution. Importantly, after
addition of E4B U box, we also observed changes in chemical
shifts for six resonances associated with amino acids in UbcH5c
and Ubc4 that are distant from the interface: Thr36, Ile37, Asp87,
Ser91, Gln92, and Ile106 (Figures 6D–6G). This is consistent with
subtle changes in flexibility or conformation, or both, that prop-
agate away from the E4B binding site. From their location in
UbcH5c and Ubc4, these residues may connect the binding
interface to the active site cysteine (Cys85) (Figure 6G), suggest-
ing a possible allosteric regulation of the enzymatic activity by
E4B through alteration of the E2 active site.
It was previously shown that binding of the RING domain of
human E3 ubiquitin ligase CNOT4 to the E2 enzyme UbcH5b
allosterically enhances the release of ubiquitin from UbcH5b-
ubiquitin thioester (Ozkan et al., 2005). Because UbcH5b is5–965, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 961
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Figure 6. NMR Titrations and Mapping of Interaction Interfaces in E4B U Box, UbcH5c, and Ubc4
(A and B) Superposition of the 1H-15N HSQC titration spectra of 15N-labeled E4B U box from free (black) to the bound (red) states with nonlabeled Ubc4 (A) and
UbcH5c (B). The arrows indicate the directions of the titrations.
(C) In the crystal structure of E4B U box and UbcH5c complex, E4B residues affected by UbcH5c titration are colored red (signals with chemical shift changesR
0.02 ppm) or blue (weakened or disappeared signals, namely those of Asp1234, Leu1236, Asp1238, Leu1247, Ile1258, Asn1271, and Arg1272). The active site
Cys85 is shown in yellow.
(D and E) Superposition of the 1H-15N HSQC titration spectra of 15N-labeled Ubc4 (D) or UbcH5c (E) from the free (black) to the bound (red) states with nonlabeled
E4B U box. The arrows indicate the directions of the titrations.
(F) In the crystal structure of E4B U box and UbcH5c complex, UbcH5c residues affected by E4B U box titration are colored red (signals with chemical shift
changes from 0.03 to 0.06 ppm) or blue (chemical shift changes from 0.07 to 0.16 ppm). The active site Cys85 is shown in yellow.
(G) UbcH5c residues distant from the binding interface with E4B U box and for which changes in chemical shifts were detected are shown in gray. The active site
Cys85 is shown in yellow.
Structure
Interaction of E4B U Box with UbcH5c and Ubc4highly similar to UbcH5c and Ubc4 (97.3% and 99.3% amino
acid identity, respectively) and the U box and RING domains
bind the same surface of the E2 enzyme, it is likely that E4B U
box contributes to the activation of UbcH5c and Ubc4. Support-
ing this possibility, the UbcH5c and Ubc4 residues not involved
in E3 binding and for which changes in chemical shifts were
observed upon interaction with the U box domain are the same
or in the vicinity of residues in UbcH5b (Ile37, Ile88, Leu89,
Ile106, and Asn114), which when mutated inhibited the RING
domain-stimulated release of ubiquitin from the active site
cysteine (Ozkan et al., 2005). More work will be needed to test
this allosteric activation hypothesis and to understand how ubiq-
uitin released from E2 is transferred to the substrate.
To examine how E4B U box bound to UbcH5c is positioned in
the context of full-length E4B, we generated a model by super-
imposing the structure of human E4B U box–UbcH5c complex
onto the structures of budding yeast Ufd2 (Tu et al., 2007) and
human UbcH5c bound noncovalently to ubiquitin (Brzovic
et al., 2006) (Figure 7). When its first 187 N-terminal amino acids
are excluded, Ufd2 has high sequence similarity (i.e., 56% simi-
larity and 30% identity) with the C-terminal half of human E4B962 Structure 18, 955–965, August 11, 2010 ª2010 Elsevier Ltd All ri(aa 560–1302), therefore making Ufd2 (aa 188–961) a reasonable
template for this segment of E4B. The region of similarity encom-
passes a large N-terminal core domain made of five repeating
units that resemble tandem Armadillo repeats and also includes
the C-terminal U box domain (Figure 7).
When the U box in the E4B U box–UbcH5c complex is overlaid
to the U box of Ufd2, the positioning of UbcH5c has few steric or
surface charge clashes with the core region of Ufd2. Moreover,
the small clashes are likely insignificant because structures of
Ufd2 from two crystal forms revealed flexibility in the hinge
region connecting the U box to the rest of the protein (Tu et al.,
2007). Normal mode calculations performed with NOMAD
(Lindahl et al., 2006) on Ufd2 also support a hinge-bending
motion of the U box relative to the protein core (data not shown).
In the overlaid structures, the orientation of UbcH5c is such that
its noncovalent ubiquitin binding site can be occupied by ubiqui-
tin. Also unhindered is the active site cysteine of UbcH5c to
which a ubiquitin molecule can be covalently linked without
creating any steric clash with the rest of the complex.
Presumably, the large E4B domain made of tandem Armadillo
repeats or residues N-terminal from this domain and lacking inghts reserved
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Figure 7. Model Structure of E4B, UbcH5c,
and Ubiquitin Ternary Complex
The structures of budding yeast Ufd2 (aa 188–961
from PDB ID code 2QIZ), human UbcH5c-ubiquitin
(PDB ID code 2FUH), and human E4B U box–
UbcH5c (this study) were superimposed to model
the complex. Ubiquitin (yellow), UbcH5c (gray),
and Ufd2 (body in green and U box in blue) fit
together in the model with very few steric clashes
and leave the active site cysteine of UbcH5c (red)
accessible to react with a ubiquitin molecule.
Structure
Interaction of E4B U Box with UbcH5c and Ubc4our model, or both, are involved in the recognition of substrate
proteins. Work is in progress to characterize full-length E4B
and its interaction with a protein substrate, a requirement to
understand the ubiquitin transfer mechanism.EXPERIMENTAL PROCEDURES
Protein Preparation
The cDNAs of full-length Ubc4 and UbcH5c were cloned in a pT7.7 vector
encoding an N-terminal noncleavable His6 tag, whereas a DNA segment cor-
responding to aa 1203–1302 of E4Bwas inserted in a pET28b vector encoding
an N-terminal His6 tag preceding a thrombin cleavage site. The proteins
were produced in Escherichia coli BL21(DE3) cells (Novagen) grown in LB
media at 37C until an A600 of about 0.8, transferred to 15C, and then induced
with 1 mM final concentration of IPTG 45 min later. Cells were harvested
12–16 hr afterward.
Cell pellets were resuspended in 50 mM sodium phosphate (pH 7.5),
300 mM NaCl (buffer 1) supplemented with 5 mM imidazole and lysed using
a high-pressure homogenizer (Emulsiflex C-5; Avestin). The soluble and insol-
uble fractions were separated by centrifugation and the lysate was loaded onto
an Ni2+-NTA column (QIAGEN). Buffer 1 with 20 and 500 mM imidazole was
used towash the column and elute the protein, respectively.Where applicable,
the His6 tag was then cleaved with thrombin at room temperature overnight,
leaving the sequence GSHKF at the N terminus of E4B U box. All proteins
were passed through a Superdex 75 size-exclusion chromatography column
(GE Healthcare) equilibrated with buffer 1.
Isotopically labeled proteins were produced using similar methods but
replacing LBmedia with M9 media containing 1 g/l [15N]NH4Cl, 4 g/l unlabeled
glucose or 2 g/l 13C-enriched glucose, 1 g/l Isogro, or 10% (v/v) Silantes OD2
media that are 15N or 15N/13C enriched and H2O or D2O (Botuyan et al., 2004).
Isotopes were purchased from Isotec and CIL.
NMR Spectroscopy
All NMR spectra were recorded at 25C using Bruker Avance spectrometers
operating at proton frequencies of 500 and 600MHz (with cryoprobe). Multiple
samples of nonlabeled, 15N-labeled, 15N/13C-labeled, and 15N/13C/2H-labeled
E4B U box were prepared at concentrations of 0.5–2 mM in 20 mM sodium
phosphate buffer (pH 7.0), 50 mM NaCl. Backbone and side-chain resonance
assignments were carried out using standard NMR experiments including
HNCO, HNCACO, HNCA, HNCOCA, HNCACB, HNCOCACB, CCONH-Structure 18, 955–965, August 11, 2010TOCSY, HCCONH-TOCSY, HBHACONH, HCCH-
TOCSY, 1H-15N TOCSY-HSQC, and 2D TOCSY
(Ferentz and Wagner, 2000). Interproton distance
restraints were derived from 15N-edited NOESY
(mixing time of 100 ms) and 13C-edited NOESY
(mixing time of 100 ms) spectra of 15N- and
15N/13C-labeled E4B, respectively, as well as
from a series of 2D NOESY spectra of nonlabeled
E4B U box recorded with mixing times of 20, 30,
50, 60, and 100 ms. All data were processed with
NMRPipe/NMRDraw (Delaglio et al., 1995) and
analyzed with NMRView (Johnson and Blevins,1994). Assignment of nuclear Overhauser effect (NOE) signals was facilitated
by using the noeassign module of CYANA 2.1 (Gu¨ntert, 2004).
Identification of Hydrogen Bonds in E4B U Box
The H bond h3JNC0, peptide bond
1JNC0, and intraresidue
3JNC0 scalar coupling
constants were measured using constant time 3D J-HNCO experiments
(Cordier et al., 1999a, 1999b; Cornilescu et al., 1999). The J-HNCO spectra
were recorded with constant times of 35 and 70 ms and with evolution times
of 16, 20, 24, 28, 32, 33, and 34 ms and 40, 50, 54, 65, 66, and 66.5 ms.
The coupling constants were determined by fitting the time evolution
of all observed NC0 couplings. H bond dHO distances [(N)H$$$O(C)] and
H-bond acceptor angles [(N)H$$$O=C] listed in Table S1 were estimated from
the magnitudes of the couplings (Juranic and Macura, 2001; Juranic et al.,
2006).
NMR Structure Calculations
NMR structure calculations were performed with CYANA 2.1 (Gu¨ntert, 2004)
using a total of 1368 NOE-derived interproton distances, 36 H bond distances
identified from slow-exchanging amide protons and from measurement of
scalar couplings as explained above, and 46 dihedral f and c angle restraints
derived from TALOS analysis (Cornilescu et al., 1999). The structures were
then refined by simulated annealing with Xplor (Schwieters et al., 2003). For
further validation of the structures, 63 1H-15N residual dipolar coupling (RDC)
restraints were included in a separate set of calculations using Xplor. The
RDCs were measured by weak alignment of E4B U box in stretched polyacryl-
amide gel (Chou et al., 2001).
Isothermal Titration Calorimetry
All ITC measurements were recorded at 22C with a VP-ITC titration calorim-
eter (MicroCal). All protein samples were in 50 mM Tris-HCl (pH 7.5), 20 mM
NaCl at concentrations of 100 mM for UbcH5c and Ubc4 and 3 mM for E4B
U box. The calorimeter syringe was used to deliver E4B U box as 50 injections
(1 3 3 ml followed by 49 3 6 ml) at 5 min intervals into the calorimetric cell
containing 1.42 ml of UbcH5c or Ubc4 solution. Control experiments were
performed under identical conditions to determine the heat signals that
arise from injecting E4B U box into the buffer solution. The initial data point
(from the first 3 ml injection) was routinely deleted. Data were analyzed by
Levenberg-Marquardt nonlinear regression fitting of each ITC isotherm using
a model corresponding to one independent binding event (Turnbull and
Daranas, 2003).ª2010 Elsevier Ltd All rights reserved 963
Structure
Interaction of E4B U Box with UbcH5c and Ubc4Crystallization and X-Ray Structure Determination
All crystals were obtained at 22C using the hanging-drop vapor-diffusion
method by mixing 1 ml of 1 mM protein solution and 1 ml of precipitant solution.
The proteins were in 50 mM Tris-HCl (pH 7.5), 50 mM NaCl. Crystals of free
E4B U box and E4B U box–UbcH5c complex grew overnight in 2 M tacsimate
and 4 M sodium formate, respectively, whereas crystals of Ubc4 formed in
2–4 days in 2.0 M sodium formate, 0.1 M sodium acetate trihydrate (pH 4.6).
The crystals were cryoprotected by soaking in the respective mother liquor
supplemented with 30% glucose and then flash-frozen in liquid nitrogen.
Diffraction data were collected at the Advanced Photon Source 19-BM
beamline, Argonne National Laboratory, for E4B U box and E4B U box–
UbcH5c complex (wavelength was 0.97918 A˚) and using a Rigaku/MSC
CuKa Microfocus 007 diffractometer at a wavelength of 1.54 A˚ for Ubc4.
Data were integrated, scaled, and merged using HKL2000 (Otwinowski and
Minor, 1997). For all structures, phasing by molecular replacement was done
using Phaser (McCoy et al., 2007). Initial model building was performed using
Coot (Emsley and Cowtan, 2004). Refinement of the structures of E4B U box in
the free state and E4B U box–UbcH5c complex was done using PHENIX
(Adams et al., 2002), whereas refinement of the structure of Ubc4 was carried
out using REFMAC5 (Murshudov et al., 1997).ACCESSION NUMBERS
Atomic coordinates and structure factors for the crystal structures of E4B
U box, E4B U box–UbcH5c complex, and Ubc4 and the NMR structure of
E4B U box have been deposited in the Protein Data Bank under ID codes
1L1X, 3L1Z, 3L1Y, and 2KRE, respectively.SUPPLEMENTAL INFORMATION
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